In murine tumor models, 113-O12B LNPs carrying OVA or TRP-2 mRNA exhibit significant tumor inhibition, with enhanced efficacy when combined with anti–PD-1 therapy, and elicit durable immune memory (Chen et al., 2022a). The gene discussed is PDCD1; the disease is neoplasm.